Edwards Lifesciences
1,223 hedge funds and large institutions have $58B invested in Edwards Lifesciences in 2021 Q3 according to their latest regulatory filings, with 124 funds opening new positions, 438 increasing their positions, 410 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 1,181 → 1,223 (+42)
7% more repeat investments, than reductions
Existing positions increased: 438 | Existing positions reduced: 410
0.11% less ownership
Funds ownership: 82.46% → 82.36% (-0.11%)
Holders
1,223
Holding in Top 10
21
Calls
$249M
Puts
$214M
Top Buyers
| 1 | +$147M | |
| 2 | +$135M | |
| 3 | +$123M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$114M |
| 5 |
Korea Investment Corp
Seoul,
South Korea
|
+$94.6M |
Top Sellers
| 1 | -$201M | |
| 2 | -$189M | |
| 3 | -$127M | |
| 4 |
KBC Group
Brussels,
Belgium
|
-$121M |
| 5 |
Bank of New York Mellon
New York
|
-$118M |